3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
139
OTHER
113
NIH
20
NETWORK
3
FED
2
UNKNOWN
1
OTHER_GOV
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Esophageal Neoplasms
24
Stomach Neoplasms
21
Rectal Neoplasms
15
Colorectal Neoplasms
12
Esophageal Squamous Cell Carcinoma
6
Carcinoma, Hepatocellular
5
Colonic Neoplasms
3
Radiation Injuries
2
Urinary Bladder Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Locally Advanced Pancreatic Cancer
1
Liver Neoplasms
1
IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer
1
HER2-positive
1
Gastrointestinal Neoplasms
1
Gastric Adenocarcinoma
1
Extrapancreatic Neuroendocrine Tumor
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Anus Neoplasms
1
Advanced Pancreatic Cancer
1
Advanced Colorectal Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Urinary Bladder Neoplasms
×
Gastrointestinal
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled